Zanubrutinib demonstrates superior progression-free survival vs ibrutinib for relapsed/refractory CLL/SLL: ALPINE final analysis
Talha Munir,Jennifer R. Brown,Barbara Eichhorst,Peter Hillmen,Nicole Lamanna,Susan M. O'Brien,Constantine S. Tam,Lugui Qiu,Maciej Kazmierczak,Wojciech Jurczak,Keshu Zhou,Martin Simkovic,Jiri Mayer,Amanda Gillespie-Twardy,Alessandra Ferrajoli,Peter S. Ganly,Robert Weinkove,Sebastian Grosicki,Andrzej Mital,Tadeusz Robak,Anders Osterborg,Habte A. Yimer,Tommi Salmi, Megan (Der Yu) Wang,Lina Fu,Jessica Li,Kenneth Wu,Aileen Cohen,Mazyar Shadman BRITISH JOURNAL OF HAEMATOLOGY(2023)
AI 理解论文
溯源树
样例